Baylor Research Institute
Baylor Research Institute sponsors 180 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 13 of these trials are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 5 trials.
Trial Pipeline
180 total, page 4 of 4
Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts
NCT01172691
A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease
NCT01194362
The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)
NCT01250548
Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB
NCT01083914
BIIR Gene to Manage Heart Allograft Patients
NCT01929785
Effect of Posture on Left Ventricular (LV) Transvenous Lead Capture Thresholds (EXPECT)
NCT01520714
Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity Resp Insufficiency
NCT01188590
Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine
NCT00473200
The Natural History of Mucolipidosis Type IV
NCT01067742
Fabry Screening Study
NCT01019629
The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants
NCT00964093
A Trial Assessing The Association Between Type Of Local Anesthesia Treatment And Postoperative Pain In Patients In Having Undergone Arrhythmia Surgery
NCT01300377
Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)
NCT00796770
Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
NCT00530686
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
NCT00722098
Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients
NCT00345384
Acute Renal Failure Post Liver Transplantation
NCT01907061
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
NCT00852163
Aquatic Exercise Study for Breast Cancer Patients With Lymphedema
NCT00498771
The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants
NCT00593684
Combined Modality Treatment for Patients With Stage IV Melanoma
NCT00313235
A Study to Examine Levels of Sedation During Outpatient Colonoscopies
NCT00614263
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
NCT00334074
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
NCT00125749
Pancreatic Islet Cell Transplantation
NCT00214786
Dosing Study of Replagal in Patients With Fabry Disease
NCT00068107
Blood Draw Study for Liver Transplant Patients
NCT01525797
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
NCT00224809
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
NCT00163657
Improving Diabetes Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse
NCT00258674
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 14 |
| Phase 3 | 2 |
| Phase 4 | 11 |
Therapeutic Areas
What the Pipeline for Baylor Research Institute Shows
According to the ClinicalTrials.gov registry, Baylor Research Institute is linked to 180 US clinical trials across every stage of research activity. Of those, 31 studies are currently recruiting, about 17% of the sponsor's indexed portfolio, and 103 are already marked complete, representing roughly 57% of the total.
The phase mix for Baylor Research Institute reports 13 late-stage studies (Phase 3 and Phase 4 combined) and 33 earlier-phase studies (Phase 1 and Phase 2).
The top therapeutic focus area indexed for Baylor Research Institute is Stroke with 5 linked trials, and 9 other condition areas appear in the top list above.
How to read these pipeline numbers
Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work, safety, dosing, and early signal detection, and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice, verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.